Enfermedad neumocócica invasiva en adultos hospitalizados: estudio de costos directos en un hospital público de la Ciudad de Buenos Aires
Respirar · 06.03.2026 · 18 (1)
DOI: 10.55720/respirar.18.1.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirar, online erschienen am 06.03.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
There are no direct cost studies of hospitalization for invasive pneumococcal disease (IPD) in Argentina.
Objectives
To determine the direct cost structure for patients hospitalized with IPD at a public hospital in City of Buenos Aires in 2022.
Methods
We evaluated adult patients hospitalized with IPD in 2022 at a public hospital. Diagnosis was confirmed by positive blood cultures for Streptococcus pneumoniae or CSF. Direct costs were determined from the funder’s perspective, based on the hospitalization cost model from the Government of the City of Buenos Aires as of June 2024, using an official exchange rate of 918 pesos per dollar.
Results
Of 24 patients with IPD, 83% had pneumonia and 17% had meningitis. The median age was 72 years (IQR 67.5-75); 54% were male; 85% were smokers; and 8.3% had a complete pneumococcal vaccination. A high prevalence of comorbidities was found (median Charlson comorbidity index 6, IQR 5-8). The median length of stay in the emergency room was 1 day (IQR 0.5-1) and 7 days on the ward (4-20). The direct cost was $3,795.91 per patient. The non-modulated direct cost was 25.65% of the total (24.1% for medications; 75.09% for tests).
Conclusion
Patients hospitalized with IPD were mostly men over 70 years old with a high burden of comorbidities. Less than 10% had full vaccine coverage. The direct cost from the funder’s perspective was $3,795.9 per patient. A quarter of the cost was not modulated. Measures should be intensified to ensure greater vaccine coverage for the at-risk population.
Zitieren
APA
(2026). Enfermedad neumocócica invasiva en adultos hospitalizados: estudio de costos directos en un hospital público de la Ciudad de Buenos Aires. Respirar, 18(1). https://doi.org/10.55720/respirar.18.1.12
Vancouver
Enfermedad neumocócica invasiva en adultos hospitalizados: estudio de costos directos en un hospital público de la Ciudad de Buenos Aires. Respirar. 2026;18(1). doi:10.55720/respirar.18.1.12
BibTeX
@article{euvimed2026,
title = {Enfermedad neumocócica invasiva en adultos hospitalizados: estudio de costos directos en un hospital público de la Ciudad de Buenos Aires},
journal = {Respirar},
year = {2026},
volume = {18},
number = {1},
doi = {10.55720/respirar.18.1.12}
}
EUVIMED